265 related articles for article (PubMed ID: 17360951)
1. Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice.
Park CW; Kim HW; Ko SH; Lim JH; Ryu GR; Chung HW; Han SW; Shin SJ; Bang BK; Breyer MD; Chang YS
J Am Soc Nephrol; 2007 Apr; 18(4):1227-38. PubMed ID: 17360951
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
Liu WJ; Xie SH; Liu YN; Kim W; Jin HY; Park SK; Shao YM; Park TS
J Pharmacol Exp Ther; 2012 Feb; 340(2):248-55. PubMed ID: 22025647
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes.
Kodera R; Shikata K; Kataoka HU; Takatsuka T; Miyamoto S; Sasaki M; Kajitani N; Nishishita S; Sarai K; Hirota D; Sato C; Ogawa D; Makino H
Diabetologia; 2011 Apr; 54(4):965-78. PubMed ID: 21253697
[TBL] [Abstract][Full Text] [Related]
4. Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta).
Young AA; Gedulin BR; Bhavsar S; Bodkin N; Jodka C; Hansen B; Denaro M
Diabetes; 1999 May; 48(5):1026-34. PubMed ID: 10331407
[TBL] [Abstract][Full Text] [Related]
5. Long-term exendin-4 treatment delays natural deterioration of glycaemic control in diabetic Goto-Kakizaki rats.
Simonsen L; Pilgaard S; Orskov C; Hartmann B; Holst JJ; Deacon CF
Diabetes Obes Metab; 2009 Sep; 11(9):884-90. PubMed ID: 19508463
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
7. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.
Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y
Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide 1 receptor agonist ZP10A increases insulin mRNA expression and prevents diabetic progression in db/db mice.
Thorkildsen C; Neve S; Larsen BD; Meier E; Petersen JS
J Pharmacol Exp Ther; 2003 Nov; 307(2):490-6. PubMed ID: 12975499
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats.
Liu WJ; Jin HY; Lee KA; Xie SH; Baek HS; Park TS
Br J Pharmacol; 2011 Nov; 164(5):1410-20. PubMed ID: 21323903
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
[TBL] [Abstract][Full Text] [Related]
11. A Human Glucagon-Like Peptide-1-albumin Recombinant Protein with Prolonged Hypoglycemic Effect Provides Efficient and Beneficial Control of Glucose Metabolism in Diabetic Mice.
Li C; Yang M; Hou G; Liu S; Huan Y; Yu D; Sun S; Liu Q; Yan S; Shen Z
Biol Pharm Bull; 2017 Sep; 40(9):1399-1408. PubMed ID: 28626167
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 Improves Diabetic Kidney Disease in C57BL/6 Mice Independent of Brown Adipose Tissue Activation.
Fang S; Cai Y; Lyu F; Zhang H; Wu C; Zeng Y; Fan C; Zou S; Zhang Y; Li P; Wang L; YaomingXue ; Guan M
J Diabetes Res; 2020; 2020():9084567. PubMed ID: 32090125
[TBL] [Abstract][Full Text] [Related]
13. Effect of alogliptin, pioglitazone and glargine on pancreatic β-cells in diabetic db/db mice.
Kawashima S; Matsuoka TA; Kaneto H; Tochino Y; Kato K; Yamamoto K; Yamamoto T; Matsuhisa M; Shimomura I
Biochem Biophys Res Commun; 2011 Jan; 404(1):534-40. PubMed ID: 21144823
[TBL] [Abstract][Full Text] [Related]
14. Long-term metabolic benefits of exenatide in mice are mediated solely via the known glucagon-like peptide 1 receptor.
Tatarkiewicz K; Sablan EJ; Polizzi CJ; Villescaz C; Parkes DG
Am J Physiol Regul Integr Comp Physiol; 2014 Apr; 306(7):R490-8. PubMed ID: 24477544
[TBL] [Abstract][Full Text] [Related]
15. Biological activity of AC3174, a peptide analog of exendin-4.
Hargrove DM; Kendall ES; Reynolds JM; Lwin AN; Herich JP; Smith PA; Gedulin BR; Flanagan SD; Jodka CM; Hoyt JA; McCowen KM; Parkes DG; Anderson CM
Regul Pept; 2007 Jun; 141(1-3):113-9. PubMed ID: 17292977
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.
Himeno T; Kamiya H; Naruse K; Harada N; Ozaki N; Seino Y; Shibata T; Kondo M; Kato J; Okawa T; Fukami A; Hamada Y; Inagaki N; Seino Y; Drucker DJ; Oiso Y; Nakamura J
Diabetes; 2011 Sep; 60(9):2397-406. PubMed ID: 21810596
[TBL] [Abstract][Full Text] [Related]
17. Combination of omeprazole with GLP-1 agonist therapy improves insulin sensitivity and antioxidant activity in liver in type 1 diabetic mice.
Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Detroja J; Patel K; Gandhi T; Patel K; Bahekar R; Jain M
Pharmacol Rep; 2013; 65(4):927-36. PubMed ID: 24145087
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.
Yin QH; Zhang R; Li L; Wang YT; Liu JP; Zhang J; Bai L; Cheng JQ; Fu P; Liu F
J Biol Chem; 2016 Dec; 291(51):26487-26501. PubMed ID: 27784780
[TBL] [Abstract][Full Text] [Related]
19. Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice.
Liu HY; Chung CY; Yang WC; Liang CL; Wang CY; Chang CY; Chang CL
J Vet Sci; 2012 Sep; 13(3):245-52. PubMed ID: 23000581
[TBL] [Abstract][Full Text] [Related]
20. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
